These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8338619)

  • 1. Oral Candida in HIV infection and AIDS: new perspectives/new approaches.
    Coleman DC; Bennett DE; Sullivan DJ; Gallagher PJ; Henman MC; Shanley DB; Russell RJ
    Crit Rev Microbiol; 1993; 19(2):61-82. PubMed ID: 8338619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation, identification, and typing of yeasts from HIV-positive patients with oral candidiasis].
    Martínez Machín G; Perurena Lancha M; Núñez Carvajal J; Fernández Andreu CM; Bandera Tirado F
    Rev Cubana Med Trop; 1997; 49(3):174-80. PubMed ID: 9685984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics.
    Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP
    Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients.
    Woldeamanuel Y; Abate D
    Ethiop Med J; 1998 Oct; 36(4):235-43. PubMed ID: 11957299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
    Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
    Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An update on Candida dubliniensis].
    Paugam A; Baixench MT; Viguié C
    Med Mal Infect; 2008 Jan; 38(1):1-7. PubMed ID: 18065177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis.
    Campanha NH; Neppelenbroek KH; Spolidorio DM; Spolidorio LC; Pavarina AC
    Oral Dis; 2005 Nov; 11(6):392-8. PubMed ID: 16269032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida dubliniensis: an emerging opportunistic pathogen.
    Sullivan D; Coleman D
    Curr Top Med Mycol; 1997 Dec; 8(1-2):15-25. PubMed ID: 9504063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical strains of Candida albicans recovered from AIDS patients.
    Pujol C; Renaud F; Mallié M; de Meeûs T; Bastide JM
    J Med Vet Mycol; 1997; 35(2):115-21. PubMed ID: 9147271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Candida albicans: the relationship between morphotypes and in-vitro adhesivity to the oral mucosa cells of HIV-positive and AIDS patients. I].
    Malighetti V; Arosio M; Bellotti MG; Spadari E; Zambellini Artini M; Spadari F; Riviera L
    Minerva Stomatol; 1998 Sep; 47(9):351-9. PubMed ID: 9835741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythematous candidosis in patients with complete dentures and HIV+/AIDS.
    Aleva NA; Birman EG; Afonso W; Chavasco JK; Paula CR; Ribeiro A; Pereira LJ
    Mycoses; 2007 Sep; 50(5):407-11. PubMed ID: 17714362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First molecular method for discriminating between Candida africana, Candida albicans, and Candida dubliniensis by using hwp1 gene.
    Romeo O; Criseo G
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):230-3. PubMed ID: 18640803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV infection and opportunistic pathology: the etiopathogenetic considerations and clinico-diagnostic aspects in candidiasis of the oral mucosa].
    Spadari F; Bauer D
    Minerva Stomatol; 1996 Mar; 45(3):81-99. PubMed ID: 8926978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida dubliniensis: epidemiology and phenotypic methods for identification.
    Loreto ES; Scheid LA; Nogueira CW; Zeni G; Santurio JM; Alves SH
    Mycopathologia; 2010 Jun; 169(6):431-43. PubMed ID: 20490751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofilm production in oral Candida isolates from HIV-positive individuals from Pune, India.
    Mane A; Kulkarni A; Risbud A
    Mycoses; 2013 Mar; 56(2):182-6. PubMed ID: 22931629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers.
    Lupetti A; Guzzi G; Paladini A; Swart K; Campa M; Senesi S
    J Clin Microbiol; 1995 May; 33(5):1238-42. PubMed ID: 7615734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification of Candida dubliniensis isolated from oral lesions of HIV-positive and HIV-negative patients in São Paulo, Brazil.
    Chavasco JK; Paula CR; Hirata MH; Aleva NA; Melo CE; Gambale W; Ruiz Lda S; Franco MC
    Rev Inst Med Trop Sao Paulo; 2006; 48(1):21-6. PubMed ID: 16547575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.